Pages that link to "Q35066127"

The following pages link to In VitroandIn VivoStudies of Monoclonal Antibodies with Prominent Bactericidal Activity against Burkholderia pseudomallei and Burkholderia mallei (Q35066127):

Displaying 27 items.

• Development of Burkholderia mallei and pseudomallei vaccines (Q26861271) (← links)
• Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development (Q27304432) (← links)
• From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK (Q27697853) (← links)
• Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders (Q30279061) (← links)
• A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis (Q33601907) (← links)
• Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate (Q33661479) (← links)
• Production and Characterization of Chimeric Monoclonal Antibodies against Burkholderia pseudomallei and B. mallei Using the DHFR Expression System (Q33900390) (← links)
• Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis (Q34058969) (← links)
• Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages (Q34075114) (← links)
• Structural analysis of capsular polysaccharides expressed by Burkholderia mallei and Burkholderia pseudomallei (Q34119552) (← links)
• Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei (Q34243707) (← links)
• A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei (Q35088366) (← links)
• A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection (Q35375333) (← links)
• Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders (Q36164961) (← links)
• Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264. (Q36392951) (← links)
• Development of novel O-polysaccharide based glycoconjugates for immunization against glanders (Q36424795) (← links)
• Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule. (Q36970284) (← links)
• Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei (Q37189868) (← links)
• Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. (Q37336008) (← links)
• Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei (Q37582243) (← links)
• Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens (Q38287677) (← links)
• Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? (Q39197155) (← links)
• A comparison of the immunological potency of Burkholderia lipopolysaccharides in endotoxemic BALB/c mice (Q40445645) (← links)
• Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection (Q45731787) (← links)
• Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis (Q47130468) (← links)
• Burkholderia pseudomallei Δ Δ Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection (Q60922209) (← links)
• Emerging role of biologics for the treatment of melioidosis and glanders (Q90569305) (← links)